يعرض 41 - 60 نتائج من 23,437 نتيجة بحث عن '(((( a largest decrease ) OR ( b large increases ))) OR ( ((i large) OR (ai large)) decrease ))*', وقت الاستعلام: 1.08s تنقيح النتائج
  1. 41
  2. 42
  3. 43
  4. 44

    Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx حسب Dewan Zhao (21547445)

    منشور في 2025
    "…High baseline high-density lipoprotein cholesterol (HDL-C) was associated with reduced progression risk (HR = 0.27, 95% CI: 0.10-0.78), while high baseline low-density lipoprotein cholesterol (LDL-C) was linked to decreased CR rate (OR = 0.65, 95% CI: 0.44-0.97) and increased progression risk (HR = 1.78, 95% CI: 1.14-2.79). …"
  5. 45

    Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

    منشور في 2022
    "…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"
  6. 46

    Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

    منشور في 2022
    "…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"
  7. 47

    Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

    منشور في 2022
    "…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"
  8. 48

    Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

    منشور في 2022
    "…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"
  9. 49

    Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

    منشور في 2022
    "…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55

    Table_2_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf حسب Tianqi Xu (9574329)

    منشور في 2021
    "…Background<p>Anaplastic diffuse large B-cell lymphoma(A-DLBCL) is a rare morphological subtype characterized by the presence of polygonal, bizarre-shaped tumor cells. …"
  16. 56

    Table_1_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf حسب Tianqi Xu (9574329)

    منشور في 2021
    "…Background<p>Anaplastic diffuse large B-cell lymphoma(A-DLBCL) is a rare morphological subtype characterized by the presence of polygonal, bizarre-shaped tumor cells. …"
  17. 57

    Decreased MBP levels in the brain in <i>Large</i><sup><i>myd/myd</i></sup> mice. حسب Shigefumi Morioka (8893511)

    منشور في 2020
    "…Decreased expression levels of MBP were observed in <i>Large</i><sup><i>myd/myd</i></sup> mice compared with those in control mice. …"
  18. 58
  19. 59
  20. 60

    Data_Sheet_1_Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.docx حسب Chengliang Yin (7545749)

    منشور في 2020
    "…However, the correlation between MMP14 expression, prognosis, and immune cell infiltration in diffuse large B-cell lymphoma (DLBCL) remains unclear.</p>Methods<p>We investigated the influence of MMP14 on clinical prognosis using data obtained from three Gene Expression Omnibus (GEO) database sets (GSE98588, GSE10846, and GSE4475). …"